Left Ventricular Performance in Patients With Severe Acute Respiratory Syndrome: A 30-Day Echocardiographic Follow-Up Study

Circulation

Volumn 108, Issue 15, 2003, Pages 1798-1803

  Li, Steven Siu Lung ^a   Cheng, Cheung Wah ^a   Fu, Chiu Lai ^a   Chan, Yiu Han ^a   Lee, Man Po ^a   Chan, Johnny Wai Man ^a   Yiu, Siu Fung ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Diastole; Echocardiography; Myocardial contraction

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; RIBAVIRIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CORONAVIRUS; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HEART CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEART OUTPUT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSTHORACIC ECHOCARDIOGRAPHY; VIRUS PNEUMONIA;

ACUTE DISEASE; ADULT; AGED; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; CONVALESCENCE; DIASTOLE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RIBAVIRIN; SEVERE ACUTE RESPIRATORY SYNDROME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0142085755     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000094737.21775.32     Document Type: Article

References (20)

1. Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772.
2. Parrillo JE. Pathogenetic mechanism of septic shock. N Engl J Med. 1993;328:1471-1477.
3. So LKY, Lau ACW, Yam LYC, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003 10;361:1615-1617.
4. Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr. 1996;9:736-760.
5. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
6. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995;26:135-136.
7. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26:357-366.
8. Dujardin KS, Tei C, Yeo TC, et al. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol. 1998;82:1071-1076.
9. Harjai KJ, Scott L, Vivekananthan K, et al. The Tei index: a new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr. 2002;15:864-868.
10. Brun P, Tribouilloy C, Duval AM, et al. Left ventricular flow propagation during early filling is related to wall relaxation: a color M-mode Doppler analysis. J Am Coll Cardiol. 1992;20:420-432.
11. Garcia MJ, Palac RT, Malenka DJ, et al. Color M-mode Doppler flow propagation velocity is a relatively preload-independent index of left ventricular filling. J Am Soc Echocardiogr. 1999;12:129-137.
12. Hoit B, Shao Y, Gabel M, et al. Influence of loading conditions and contractile state on pulmonary venous flow: validation of Doppler vclocimetry. Circulation. 1992;86:651-659.
13. Galiuto L, Ignone G, DeMaria A. Contraction and relaxation velocities of the normal left ventricle using pulsed wave tissue Doppler echocardiography. Am J Cardiol. 1998;81:609-614.
14. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1977-1985.
15. Lee N, Hui D, Wu A, et al. A major outbreak of SARS in Hong Kong. N Engl J Med. 2003;348:1986-1994.
16. Mann DL. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res. 2002;91:988-998.
17. Alexander LK, Keene BW, Small JD, et al. Electrocardiographic changes following rabbit coronavirus-induced myocarditis and dilated cardiomyopathy. Adv Exp Med Biol, 1993;342:365-370.
18. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histological definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
19. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:269-275.
20. Pinsky MR. Cardiovascular effects of ventilatory support and withdrawal. Anesth Analg. 1994;79:567-576.